Biblio
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024.
Identification of a novel NPM1 mutation in acute myeloid leukemia. Exp Hematol Oncol. 2023;12(1):87.
. HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML. Aging (Albany NY). 2020;12.